Publikationen, an denen er mitarbeitet ANDRÉS JESÚS MUÑOZ MARTÍN (9)

2023

  1. Cost-effectiveness of apixaban and rivaroxaban in thromboprophylaxis of cancer patients treated with chemotherapy in Spain

    Journal of Medical Economics, Vol. 26, Núm. 1, pp. 1145-1154

2021

  1. Early clinical experience with trifluridine/tipiracil for refractory metastatic colorectal cancer: The ros study

    Cancers, Vol. 13, Núm. 18

  2. First-Line Biological Agents Plus Chemotherapy in Older Patients with Metastatic Colorectal Cancer: A Retrospective Pooled Analysis

    Drugs and Aging, Vol. 38, Núm. 3, pp. 219-231

  3. Molecular Profiling and Targeted Therapy in Cholangiocarcinoma: An Observational, Retrospective Multicenter Study

    Journal of Gastrointestinal Cancer, Vol. 52, Núm. 2, pp. 814-818

2019

  1. FOLFOXIRI plus biologics in advanced colorectal cancer

    Expert Opinion on Biological Therapy, Vol. 19, Núm. 5, pp. 411-422

2018

  1. Single-Agent Regorafenib in Metastatic Colorectal Cancer Patients with Any RAS or BRAF Mutation Previously Treated with FOLFOXIRI plus Bevacizumab (PREVIUM Trial)

    Oncologist, Vol. 23, Núm. 11, pp. 1271-e128

2017

  1. Tratamiento médico para el manejo integral de las metástasis hepáticas en cáncer colorrectal

    Revisiones en Cancer, Vol. 31, Núm. 4, pp. 166-173

2015

  1. Capecitabine and irinotecan with bevacizumab 2-weekly for metastatic colorectal cancer: The phase II AVAXIRI study

    BMC Cancer, Vol. 15, Núm. 1

2010

  1. Linfoma no Hodgkin en gestación: linfoma linfoblástico T y revisión de la literatura

    Acta ginecológica: Revista de ginecología, obstetricia y reproducción humana, Vol. 67, Núm. 1, pp. 1-7